Combination for reducing oxidative stress in the body and maintaining liver functions
A synergistic composition of hydrolytic lignin and dihydromyricetin or quercetin effectively reduces oxidative stress markers and supports liver function by decreasing MDA and AA levels, addressing liver damage from alcohol and drug poisoning.
Patent Information
- Application Number
- GB2023008887
- Authority / Receiving Office
- GB · GB
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-11-17
- Filing Date
- 2021-11-16
- Publication Date
- 2026-01-14
- Estimated Expiration
- 2041-11-16
AI Technical Summary
Existing compositions fail to effectively reduce oxidative stress and its inducers in the blood and human organs while maintaining liver functions, particularly in conditions such as alcohol and drug poisoning, leading to increased levels of malondialdehyde (MDA) and acetaldehyde (AA), which are associated with various diseases and liver damage.
A composition combining hydrolytic lignin and dihydromyricetin or quercetin in specific amounts, providing a synergistic effect to decrease MDA and AA levels and support liver detoxification, formulated as an oral dosage form, dietary supplement, or therapeutic nutrition product.
The combination significantly reduces oxidative stress markers and maintains liver function by decreasing MDA and AA levels, enhancing antioxidant capacity, and protecting against liver damage, including from alcohol and drug-induced toxicity.